Fulltext

One year survivor of metastatic renal cell carcinoma treated with pazopanib

Inn FX 1 , Ahmed N 1 , Hing EY 2 , Jasman MH 1

Affiliations 

  • 1 Department of Surgical, Urology Unit, UKM Medical Center, 56000 Cheras, Kuala Lumpur, Malaysia
  • 2 Department of Radiology, UKM Medical Center, 56000 Cheras, Kuala Lumpur, Malaysia
Urol Ann, 2017 5 10;9(2):194-196.
PMID: 28479777 DOI: 10.4103/0974-7796.204178

Abstract

Tyrosine kinase inhibitor (TKI) and its side effects are well known. However, these are mainly descriptive, with pictorial data lacking. Here, in we report a case of metastatic renal cell carcinoma, treated with TKI, with classic side effects; supplemented with images that demonstrate the adverse effects of the drug. In addition, we discuss and demonstrate the computed tomography changes.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications